Vision bill lets states opt out of patient protections with a single clause
S. 1716 — Vision Lab Choice Act of 2025 · Filed by Kevin Cramer (R-ND) · 23 cosponsors · Introduced May 12, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends federal health insurance law to require that optometrists in vision plans cannot be restricted in their choice of laboratories or suppliers for materials and services they provide to patients. It limits initial optometry agreements to 2-year terms (renewable with consent) and requires the federal government to annually notify states of their authority to enforce these rules, treating non-enforcement as a failure to comply with federal standards.
Why we flagged it
The bill's operative mechanism restricts insurer control over lab choice and agreement terms, framed as consumer protection. However, the final section grants states exclusive jurisdiction to override federal requirements, effectively creating a deregulation pathway for states that choose not to enforce the bill's protections.
What the text implies
- The state-law preemption clause (final section) allows states to pass laws that directly conflict with and nullify the bill's protections, potentially creating a race-to-the-bottom where states with strong insurance-industry lobbying exempt themselves from the federal standard.
- By requiring annual federal notification to states and treating non-response as non-enforcement, the bill creates a federal-state enforcement gap that may leave patients in non-compliant states without remedy.
The full analysis lists 4 implications of this text.
Who stands to gain
independent optical laboratories; optometry practices (especially independent practitioners); optical suppliers and materials vendors